Aytu BioPharma, Inc.
AYTU · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $17,749 | $14,806 | $7,362 | $10,425 |
| - Cash | $32,630 | $30,952 | $18,173 | $20,398 |
| + Debt | $1,857 | $22,937 | $22,523 | $17,140 |
| Enterprise Value | -$13,024 | $6,791 | $11,712 | $7,167 |
| Revenue | $13,888 | $15,135 | $18,452 | $16,221 |
| % Growth | -8.2% | -18% | 13.8% | – |
| Gross Profit | $9,186 | $10,254 | $12,806 | $10,786 |
| % Margin | 66.1% | 67.8% | 69.4% | 66.5% |
| EBITDA | $3,284 | -$17,419 | $6,035 | $2,634 |
| % Margin | 23.6% | -115.1% | 32.7% | 16.2% |
| Net Income | $1,965 | -$19,818 | $3,994 | $788 |
| % Margin | 14.1% | -130.9% | 21.6% | 4.9% |
| EPS Diluted | -0.08 | -2.92 | 0.21 | -0.26 |
| % Growth | 97.3% | -1,490.5% | 180.8% | – |
| Operating Cash Flow | -$618 | $2,803 | -$6,455 | $2,905 |
| Capital Expenditures | $0 | -$17 | -$69 | -$6 |
| Free Cash Flow | -$618 | $2,786 | -$6,524 | $2,899 |